There is more evidence that shingles vaccination significantly decreases the risk for heart disease, dementia and death among ...

Patients with sickle cell disease and beta-thalassemia treated with exagamglogene autotemcel reported substantial and ...

Younger ophthalmologists need to hear the message of proper ergonomics as early as possible, according to a speaker at the ...

Adults with COPD receiving roflumilast had a smaller COPD exacerbation rate at 1 year vs. those receiving azithromycin but ...

Differences in bone quality between nonarthritic and arthritic ankles may illuminate future intervention strategies for ankle ...

Every medical innovation is usually met with both some excitement and some appropriate skepticism. If someone today ...

The FDA has approved obinutuzumab for the treatment of adults with active lupus nephritis who are receiving standard therapy, ...

GLP-1 receptor agonists and fenofibrate medications significantly reduced the risk for developing diabetic macular edema, ...

Music with more predictability was shown to “entrain” listeners’ blood pressure, suggesting music-based BP modulation ...

The FDA approved expanded indications of Yuflyma and its unbranded version to treat hidradenitis suppurativa in adolescents aged 12 years and older and uveitis in children aged 2 years and older, ...

The FDA has granted 510(k) clearance to a blood-based biomarker test indicated for early detection of Alzheimer’s disease and other causes of cognitive decline within a primary care setting, according ...

Novo Nordisk announced its oral GLP-1 has been approved by the FDA to reduce risk for major adverse cardiovascular events in high-risk adults with type 2 diabetes.Approval of oral semaglutide ...